Verastem, Inc. (VSTM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.37-0.01 (-0.72%)
At close: 4:00 PM EDT
People also watch:
STMLOMEDCCXIEPZMTTPH
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.36
Prev Close1.38
Bid1.37 x 3100
Ask1.45 x 4000
Day's Range1.36 - 1.40
52wk Range1.05 - 2.43
1y Target EstN/A
Market Cap50.68M
P/E Ratio (ttm)-1.15
Beta2.82
Volume67,649
Avg Vol (3m)219,745
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire21 days ago

    Verastem to Present at Rodman & Renshaw 18th Annual Global Investment Conference

    Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13th at 10:25 AM Eastern Time at The Lotte New York Palace Hotel.

  • Associated Press2 months ago

    Verastem reports 2Q loss

    On a per-share basis, the Needham, Massachusetts-based company said it had a loss of 23 cents. Losses, adjusted for stock option expense, were 18 cents per share. The results exceeded Wall Street expectations. ...

  • Business Wire2 months ago

    Verastem Reports Second Quarter 2016 Financial Results

    Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today reported financial results for the second quarter ended June 30, 2016, and also provided an overview of certain corporate developments.